BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32945503)

  • 1. Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF‑α.
    Fu J; Zhou H; Chen J; Wang Y
    Oncol Rep; 2020 Oct; 44(4):1616-1626. PubMed ID: 32945503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of lncRNA UCA1-related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma.
    Zhou H; Shen Q; Fu J; Jiang F; Wang L; Wang Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23312. PubMed ID: 32249461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma.
    Chen J; Jiang F; Hu L; Zhang F; Wang J; Huang K; Wang Y
    Biomed Res Int; 2020; 2020():2806042. PubMed ID: 32626737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis.
    Lee JH; Kang MJ; Han HY; Lee MG; Jeong SI; Ryu BK; Ha TK; Her NG; Han J; Park SJ; Lee KY; Kim HJ; Chi SG
    Clin Cancer Res; 2011 Dec; 17(24):7551-62. PubMed ID: 21980136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of ubiquitin‑specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc‑finger E‑box binding homeobox 1.
    Zhou F; Du C; Xu D; Lu J; Zhou L; Wu C; Wu B; Huang J
    Mol Med Rep; 2020 Aug; 22(2):1382-1390. PubMed ID: 32468048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells.
    Zhang L; Liu X; Tang Z; Li X; Wang G
    Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
    Sui C; Meng F; Li Y; Jiang Y
    J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
    Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
    APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma.
    Du H; Chen B; Jiao NL; Liu YH; Sun SY; Zhang YW
    Oxid Med Cell Longev; 2020; 2020():7370157. PubMed ID: 32215178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms of cisplatin resistance development in human lung cancer cells.
    Okamoto K; Saito Y; Narumi K; Furugen A; Iseki K; Kobayashi M
    Biochem Biophys Res Commun; 2020 Oct; 530(4):745-750. PubMed ID: 32782152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
    Zhou W; Wang J; Man WY; Zhang QW; Xu WG
    Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
    Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
    J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
    Wei Y; Wu S; Xu W; Liang Y; Li Y; Zhao W; Wu J
    Thorac Cancer; 2017 Jan; 8(1):26-32. PubMed ID: 27813328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inverse interaction between
    Zhang Y; Yuan Y; Li Y; Zhang P; Chen P; Sun S
    Epigenetics; 2019 Oct; 14(10):949-960. PubMed ID: 31144606
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
    Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
    Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.